Ornovi

Ornovi, Inc., headquartered in Irvine, California, is a rapidly emerging biotechnology company founded by world-class drug developers who have achieved success at Bonti and Allergan (now part of AbbVie). The team is committed to transforming the treatment paradigm for patients with inflammatory/immune diseases. The initial focus is on inflammatory skin conditions, starting with alopecia areata and vitiligo, representing a significant opportunity to offer patients better and safer treatment options. Ornovi aims to improve lives by pursuing new technologies and developing them into solutions that benefit both patients and healthcare providers, addressing a potential multibillion-dollar market opportunity.